Hotel Clarendon, Québec City
Dr. Tonelli welcomed the group to Quebec City and thanked them for their attendance. He asked that all participants introduce themselves to the group. Dr. Tonelli asked Ms. Borne if the current version of the agenda had any last minute alterations, none were noted.
Dr. Tonelli congratulated Dr. Thombs on his appointment as the next Chair of the CTFPHC, and noted that from now until October 2017, Dr. Thombs would act as chair-elect, until Dr. Tonelli’s service term comes to an end.
Dr. Tonelli also announced that Dr. Lewin would be the next Vice-Chair of the CTFPHC, taking over from Dr. Birtwhistle. As of October 2016, Dr. Birtwhistle’s service term has now come to an end.
Dr. Tonelli asked everyone to take time to review the Minutes and PROM from the previous meeting and if they had any changes, to let Ms. Priel know. Ms. Borne made the group aware that just before this meeting, Mr. Beck had sent Ms. Priel a small revision to the previous meeting minutes. The minutes were updated accordingly.
Dr. Tonelli provided information regarding the Task Force Members Alumni. The Alumni is described as past members, who still continue on guideline working groups of which they are members, they take part in calls and they also provide new Task Force members with valuable institutional experience. Dr. Birtwhistle, Dr. Singh, Dr. Bacchus, Dr. Pottie and Dr. Dickinson are now considered Alumni members, as their terms have come or are coming to an end.
Dr. Thombs provided the group with an update and presentation. His presentation looked at the progress of the working group so far, the current status of the guideline and next steps. He thanked the working group for all their hard work to help develop this guideline and also thanked all Task Force members for their valuable contributions.
Dr. Grad gave a presentation to the group covering the background work behind the Hep C guideline development and the newly revised draft recommendations. He was joined by Dr. Chris Greenaway for part of this presentation.
Dr. Wilson gave a presentation, updating the group on the progress of the working group and asked for approval of the protocol.
Dr. Singh gave an update to the group on the progress of the working group and presented the revised recommendations for consideration.
Dr. Thombs gave a presentation updating the group on Topics and gave further information on topic selection.
Ms. Jaramillo began her presentation to the group with an update of progress made by the working group since the last In Person Meeting in June 2016. She covered Methods that are complete, in progress and pending.
Dr. Pottie presented the group with background on the development of Feasibility, Acceptability, Cost and Equity (FACE) – a new tool for stakeholder engagement.
Ms. Pillay from ARCHE and Ms. Stevens from OHRI provided the group with a presentation on the ERSC’s experience in working with the Task Force for the last year. Their presentation looked at some lessons learned, provided background to support changes underway and gave opportunity for discussion on upcoming timelines.
Dr. Klarenbach gave the group a presentation on the progress of the working group. His presentation looked at how this revision to the original guideline will help with future guideline updates.
Dr. Bashir presented the progress of the KT working group and advised the group that changes are being made to the KT tool development process.
Ms. Kretschmer gave a high level presentation of the current timelines.
Dr. Thombs provided an update to the group on the work of the working group and presented criteria changes to key questions 1 and 2 for approval by the Task Force.
Dr. Groulx gave the group an update of progress by the working group and presented the protocol for approval by the Task Force. Dr. Rodin explained more about overdiagnosis; a pilot approach is being used that could also be used for Task Force systematic reviews guideline topics.
Dr. Birtwhistle provided the group with some information on the BC Lifetime Prevention Schedule Expert Advisory Committee.
Dr. Rodin gave a presentation to the group, updating them on the work and accomplishments of the Global Health and Guidelines Division (GHGD).
Dr. Tonelli gave an update on his meeting with the Health Minister, The Right Honourable Jane Philpot and the President of the Public Health Agency (PHAC).
Dr. Tonelli asked Ms. Borne if she had any other points to add. Ms. Borne advised the group that the Task Force travel committee needs 1 new member. She also advised that the next In Person Meeting will be held on Feb 27 & 28, 2016, in Toronto if an affordable space can be found. More details on this to follow.
Dr. Moore delivered a presentation to the group detailing progress made by the working group and sought protocol approval from the Task Force.
Dr. Birtwhistle advised the group that work on the adaptation of the USPSTF Thyroid Dysfunction guideline, will begin again, now that the larger more complex guidelines are progressing well.
Ms. Radha Sayal provided the group with an update and presentation on the progress of the eHealth working group. She gave a live demonstration of the EMR Breast Cancer plug in, in OSCAR.
Mr. Rodier provided an update via teleconference, with a presentation on the work of Hill and Knowlton and the CTFPHC brand. He gave details on the process of guideline media launch and the role social media can play in guideline release.
Dr. Tonelli thanked everyone for their attendance and advised that the next meeting would be held in Toronto in February. He thanked Ms. Borne and Ms. Priel for planning a great meeting.